Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Panlongqi Tablet in Patients With Knee Osteoarthritis:A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel Study

NCT03327012 is registered in ClinicalTrials.gov with Guang'anmen Hospital of China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT03327012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03327012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Panlongqi Tablet in Patients With Knee Osteoarthritis:A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel Study
Lead sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Phase
Phase 3
Overall status
Unknown status
Start date
November 1, 2017
Completion date
July 28, 2019
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis